CXCL1 and neoplasm: Additionally, Niu et al. demonstrate that the tumor cell intrinsic loss of SETD2 in pancreatic cancer cells boosted the PI3K signaling and expression of CXCL1, promoting neutrophil recruitment and immunosuppression [65].